EcoR1 Capital, LLC 13D/13G Filings for iTeos Therapeutics, Inc. (ITOS)

EcoR1 Capital, LLC 13D and 13G filings for iTeos Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
6:04 pm
Sale
2024-09-3013GiTeos Therapeutics, Inc.
ITOS
EcoR1 Capital, LLC1,608,616
4.400%
-336,056decrease
(-17.28%)
Filing
2024-02-16
12:54 pm
Purchase
2024-02-0513GiTeos Therapeutics, Inc.
ITOS
EcoR1 Capital, LLC1,944,672
5.400%
1,944,672increase
(New Position)
Filing